Volume 22, Number 8—August 2016
Research
Enterovirus D68 Infection in Children with Acute Flaccid Myelitis, Colorado, USA, 2014
Table 4
EV-D68 association with acute neurologic disease compared with that of RPP-tested and BP–tested controls, adjusted models*
Exposure |
RPP-tested controls† | BP-tested controls‡ | |||
---|---|---|---|---|---|
OR (95% CI) |
p value |
OR (95% CI) |
p value |
||
EV-D68 | 12.9 (2.5–76.4)† | 0.002 | 5.7 (1.3–25.5‡ | 0.02 | |
EV/RV excluding EV-D68 | 6.9 (0.8–66.0)§ | 0.08 | 2.5 (0.4–13.9)¶ | 0.30 |
*Of 13 cases of neurologic disease identified in Colorado during the outbreak period, only 12 provided nasopharyngeal specimens for analysis. RPP models were adjusted for age, time to specimen collection, epidemiologic week of sample collection. B. pertussis models were adjusted for presence of fever, type of specimen collected, and epidemiologic week of specimen collection. BP, Bordetella pertussis; EV, enterovirus; OR, odds ratio; RPP, respiratory pathogen panel; RV, rhinovirus.
†n = 102.
‡n = 226.
§n = 96.
¶n = 195.
Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.